Search Results 641-650 of 10063 for Cryptococcal meningitis

  1. Deep learning models allow H&E to identify meningioma molecular subtypes - Mayo Clinic

    A Mayo Clinic researcher says the models might provide an alternative to genetic profiling. The new approach could widen access to personalized meningioma ...

  2. Meningioma - Doctors and departments - Mayo Clinic

    ... meningitis. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Research. With state-of-the-art research and laboratory facilities, Mayo Clinic ...

  3. A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy - Mayo Clinic

    Known active CNS metastases and/or carcinomatous meningitis. Note: Participants with previously treated brain metastases may participate provided they are ...

  4. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  5. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  6. Moyamoya disease care at Mayo Clinic

    Neurosurgeon Bernard R. Bendok, MD, describes moyamoya treatment options and goals at Mayo Clinic.

  7. Meningioma - Doctors and departments - Mayo Clinic

    ... meningitis. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Brian A. Neff, M.D.. Otolaryngologist. Rochester, MN. Areas of focus ...

  8. Pembrolizumab In Treating Patients With Small Bowel Adenocarcinoma That Is Metastatic Or Locally Advanced And Cannot Be Removed By Surgery - Mayo Clinic

    ... meningitis which is excluded regardless of clinical stability; Active autoimmune disease (including but not limited to: patients with a history of ...

  9. Meningioma - Doctors and departments - Mayo Clinic

    ... meningitis, Benign brain tumor. Show more areas of focus for Maciej M. Mrugala, M.D., Ph.D. Research. With state-of-the-art research and laboratory facilities ...

  10. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

    NMDAR encephalitis is a life‑threatening, antibody-mediated autoimmune disorder of the central nervous system. Standard of care includes high-dose ...